Last reviewed · How we verify
Standard of care_2
Standard of care_2 is a Small molecule drug developed by Ain Shams University. It is currently in Phase 3 development for Various cancers. Also known as: Steroid.
This drug is a standard of care treatment.
This drug is a standard of care treatment. Used for Various cancers.
At a glance
| Generic name | Standard of care_2 |
|---|---|
| Also known as | Steroid |
| Sponsor | Ain Shams University |
| Modality | Small molecule |
| Therapeutic area | Oncology |
| Phase | Phase 3 |
Mechanism of action
It is used to treat various conditions, but the exact mechanism is not specified.
Approved indications
- Various cancers
Common side effects
- Unknown
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Standard of care_2 CI brief — competitive landscape report
- Standard of care_2 updates RSS · CI watch RSS
- Ain Shams University portfolio CI
Frequently asked questions about Standard of care_2
What is Standard of care_2?
Standard of care_2 is a Small molecule drug developed by Ain Shams University, indicated for Various cancers.
How does Standard of care_2 work?
This drug is a standard of care treatment.
What is Standard of care_2 used for?
Standard of care_2 is indicated for Various cancers.
Who makes Standard of care_2?
Standard of care_2 is developed by Ain Shams University (see full Ain Shams University pipeline at /company/ain-shams-university).
Is Standard of care_2 also known as anything else?
Standard of care_2 is also known as Steroid.
What development phase is Standard of care_2 in?
Standard of care_2 is in Phase 3.
What are the side effects of Standard of care_2?
Common side effects of Standard of care_2 include Unknown.
Related
- Manufacturer: Ain Shams University — full pipeline
- Therapeutic area: All drugs in Oncology
- Indication: Drugs for Various cancers
- Also known as: Steroid
- Compare: Standard of care_2 vs similar drugs
- Pricing: Standard of care_2 cost, discount & access